Developing affordable cervical cancer screening and treatment for women with HIV
Project 1
['FUNDING_OTHER'] · UNIVERSITY OF TX MD ANDERSON CAN CTR · NIH-10895287
This study is working to improve how we find and treat cervical cancer in women living with HIV in Brazil and Mozambique, using new and affordable methods, including technology, to make healthcare better for them.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF TX MD ANDERSON CAN CTR (nih funded) |
| Locations | 1 site (HOUSTON, UNITED STATES) |
| Trial ID | NIH-10895287 on ClinicalTrials.gov |
What this research studies
This research aims to create sustainable infrastructure for addressing HIV-associated malignancies, particularly cervical cancer, in women living with HIV in Brazil and Mozambique. The project focuses on developing innovative, low-cost, and technologically feasible methods for screening, diagnosing, and treating cervical cancer. By collaborating with experts in various fields, the research will implement multi-institutional studies to improve healthcare outcomes for women affected by HIV. The approach includes leveraging artificial intelligence and algorithmic analyses to enhance the effectiveness of cancer care.
Who could benefit from this research
Good fit: Ideal candidates for this research are women living with HIV, particularly those in low- and middle-income countries who are at risk for cervical cancer.
Not a fit: Patients who do not have HIV or are not at risk for cervical cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve cervical cancer outcomes for women living with HIV in low- and middle-income countries.
How similar studies have performed: Previous research has shown success in developing low-cost cancer screening methods in similar populations, indicating a promising avenue for this approach.
Where this research is happening
HOUSTON, UNITED STATES
- UNIVERSITY OF TX MD ANDERSON CAN CTR — HOUSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KREITCHMANN, REGIS — UNIVERSITY OF TX MD ANDERSON CAN CTR
- Study coordinator: KREITCHMANN, REGIS
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: AIDS associated cancer, AIDS related cancer, Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus